谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

An Open-Label Study of Pemigatinib in Cholangiocarcinoma: Final Results from FIGHT-202

A. Vogel,V. Sahai,A. Hollebecque, G. M. Vaccaro,D. Melisi, R. M. Al Rajabi,A. S. Paulson,M. J. Borad,D. Gallinson,A. G. Murphy,D. -Y. Oh,E. Dotan,D. V. Catenacci,E. Van Cutsem, C. F. Lihou,H. Zhen,M. L. Veronese, G. K. Abou-Alfa

ESMO OPEN（2024）

引用 0|浏览14
暂无评分
关键词
intrahepatic cholangiocarcinoma,precision medicine,next-generation sequencing,fibroblast growth factor receptor,pemigatinib,targeted therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要